| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |